CHF10073
/ Chiesi
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 13, 2026
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF10073 After Single and Multiple Doses in Healthy Volunteers and the Effect of Itraconazole on CHF10073 Exposure
(clinicaltrials.gov)
- P1 | N=155 | Completed | Sponsor: Chiesi Farmaceutici S.p.A. | Recruiting ➔ Completed
Trial completion • Immunology • Pulmonary Disease • Respiratory Diseases
1 to 1
Of
1
Go to page
1